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The transcription factors Nanog and Gata6 are critical to specify the epiblast versus primitive endoderm (PrE)
lineages. However, little is known about the mechanisms that regulate the protein stability and activity of these
factors in the developing embryo. Here we uncover an early developmental function for the Polycomb group
member Bmi1 in supporting PrE lineage formation through Gata6 protein stabilization. We show that Bmi1 is
enriched in the extraembryonic (endoderm [XEN] and trophectodermal stem [TS]) compartment and repressed by
Nanog in pluripotent embryonic stem (ES) cells. In vivo, Bmi1 overlaps with the nascent Gata6 and Nanog protein
from the eight-cell stage onward before it preferentially cosegregates with Gata6 in PrE progenitors. Mechanis-
tically, we demonstrate that Bmi1 interacts with Gata6 in a Ring finger-dependent manner to confer protection
against Gata6 ubiquitination and proteasomal degradation. A direct role for Bmi1 in cell fate allocation is
established by loss-of-function experiments in chimeric embryoid bodies. We thus propose a novel regulatory
pathway by which Bmi1 action on Gata6 stability could alter the balance between Gata6 and Nanog protein levels
to introduce a bias toward a PrE identity in a cell-autonomous manner.
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During early mouse development, the transition from
morula to blastocyst around embryonic day 3.5 (E3.5)
marks the onset of differentiation into the inner cell mass
(ICM) and trophectoderm (TE) (Jedrusik et al. 2008; Rossant
2008). At this stage, the ICM is heterogeneous and com-
posed of pluripotent epiblast and extraembryonic primitive
endoderm (PrE) progenitors, as revealed by a ‘‘salt-and-
pepper’’ distribution of the key epiblast (Nanog) and
PrE (Gata6) markers at E3.75 (Koutsourakis et al. 1999;
Chambers et al. 2003, 2007; Mitsui et al. 2003; Chazaud
et al. 2006; Plusa et al. 2008; Silva et al. 2009). Compart-
mentalization of two distinct expression domains for
Nanog and Gata6 is then achieved by cell sorting and
apoptosis and strictly delineates the newly formed epi-
blast and PrE lineages (E4.5) (Plusa et al. 2008; Meilhac
et al. 2009). These confined expression patterns are stably
maintained in blastocyst-derived embryonic (ES) and ex-
traembryonic endoderm (XEN) stem cells—two cell pop-
ulations that retain the properties of the epiblast and PrE,
respectively (Evans andKaufman 1981;Martin 1981; Kunath
et al. 2005; Rossant 2008). Prior to blastocyst formation,
however, Nanog and Gata6 are seen to overlap in most cells
from the eight-cell up to the morula stage. This early ex-
pression pattern is also characterized by highly dynamic and
variable protein levels among blastomeres (Dietrich and
Hiiragi 2007; Plusa et al. 2008). HowNanog and Gata6 seg-
regation is triggered and how their expression is stabilized in
the epiblast and PrE progenitors remain largely unknown.
Epigenetic factors have emerged as key regulators of cell
fate decisions during early development (Torres-Padilla
et al. 2007). Among them, the Polycomb-repressive com-
plexes PRC1 (Ring1A, Ring1B, Bmi1, andMel18) and PRC2
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(Ezh2, Suz12, and Eed) are known to maintain the early-
determined gene expression patterns of key developmental
regulators such as homeobox genes (Satijn and Otte 1999;
van Lohuizen 1999). In the early embryo, PRCs are involved
in specifying epigenetic asymmetry between parental
genomes (Arney et al. 2001; Santos et al. 2005; Puschendorf
et al. 2008). Loss-of-function studies also demonstrated
a crucial role for these complexes in maintaining the in-
tegrity of ES cells in culture (Azuara et al. 2006; Boyer
et al. 2006; Jorgensen et al. 2006; Leeb and Wutz 2007;
Chamberlain et al. 2008; Endoh et al. 2008; van der Stoop
et al. 2008). Although Polycomb group members are dy-
namically expressed throughout preimplantation devel-
opment (O’Carroll et al. 2001; Puschendorf et al. 2008),
their specific function in blastocyst lineage formation
remains elusive. In this study, we identified a novel regu-
latory pathway that underlies cell fate allocation during
early development. This process mechanistically links Bmi1
to the lineage-specific transcription factorsNanog andGata6.
We show that Bmi1 is repressed by Nanog in ES cells
and highly expressed in extraembryonic endoderm ([XEN]
and trophectodermal [TS]) stem cells where Nanog is not
present. In vivo investigation of expression patterns by
immunostaining and single-cell PCR analysis established
that Bmi1 first overlaps with Nanog and Gata6 to then
preferentially segregate alongside Gata6 in PrE progenitors.
In the absence of Bmi1, PrE formation is severely impaired
in a cell-autonomous manner, as demonstrated in vitro in
chimeric embryoid bodies (EBs). Critically, we demon-
strate that Bmi1 physically interacts with Gata6 in PrE-
derived XEN cells and controls its protein stability and
resultant activity by inhibiting Gata6 ubiquitination and
proteasome-mediated degradation. Collectively, these find-
ings provide novel evidence to suggest how Bmi1 action on
Gata6 stability could impact on cell fate decisions between
epiblast and PrE lineages, most likely by altering the
balance between Nanog and Gata6 protein levels in indi-
vidual cells. Interestingly, Bmi1 also interacts with and
maintains high Gata3 protein levels in TE-derived TS cells
(Tanaka et al. 1998), suggesting a broader function for Bmi1
in extraembryonic lineage formation and/or maintenance.
Results
Bmi1 is a direct target of Nanog in pluripotent
stem cells
To investigate a possible transcriptional link between
Nanog and PRC members, we took advantage of geneti-
cally modified ES cell lines with distinct Nanog expres-
sion levels (Chambers et al. 2003, 2007). Quantitative
RT–PCR (qRT–PCR) analysis was performed in control
RCN(t), Nanog/ RCNbH(t), and Nanog-overexpressing
EF4 ES cells maintained in self-renewing conditions
(Fig. 1A). Among the PRCmembers analyzed, Bmi1was
uniquely identified as being expressed inversely toNanog
(Fig. 1A; data not shown). While detected at low levels in
control cells, Bmi1 transcript was markedly up-regulated
in RCNbH(t) cells and repressed in EF4 cells, suggesting
thatNanog negatively controlsBmi1 expression in ES cells.
Eight putative Nanog-binding sites (BS) were identified
across the Bmi1 locus based on the Nanog consensus se-
quence motif (Supplemental Fig. S1A; Mitsui et al. 2003).
Nanog occupancy was assessed at these sites by chromatin
immunoprecipitation (ChIP)-qPCR in undifferentiated ES
cells. Results showed high enrichment levels at BS1 lo-
cated 4 kb upstream of the Bmi1 transcription start site in
Nanog-expressing cells but not in Nanog/ ES cells, as
expected (Fig. 1B; Supplemental Fig. S1B).Gata6, a known
Nanog target gene, was used as positive control in these
experiments (Singh et al. 2007; Frankenberg et al. 2011). To
directly assess Nanog action on Bmi1 expression, a 1.9-kb
fragment from the Bmi1 regulatory region spanning BS1
(Bmi1 Reg) was inserted into a pGL3 promoter vector, and
the luciferase reporter construct was transfected into
HEK293 cells. Cotransfection with Nanog significantly
reduced Bmi1 Reg activity (Fig. 1C). This repressive effect
was abolished when BS1 was mutated (Bmi1 Reg MUT),
demonstrating that Nanog represses Bmi1 expression via
the identified binding site.
Bmi1 expression is mosaic among undifferentiated
ES cells
Nanog is heterogeneously expressed within Oct3/4-pos-
itive ES cell cultures (Chambers et al. 2007; Singh et al.
2007). A knock-in GFP/Nanog reporter line (TNG) revealed
that ES cells oscillate between Nanog-low and Nanog-high
states, with Nanog-low cells being more prone to differen-
tiate (Chambers et al. 2007). Using the same TNG reporter
line, we checkedwhether Bmi1was predominantly present
in primed, Nanog-low ES cells. Immunostaining revealed a
mosaic expression pattern for Bmi1within ES cell colonies.
As illustrated in Figure 1D, low levels of Bmi1 protein were
detected in a manner mutually exclusive to GFP/Nanog
signals. This was confirmed at the mRNA level in FACS-
sorted GFP/Nanog-low and GFP/Nanog-high ES cell pop-
ulations (Fig. 1E). In contrast toNanog,Oct3/4 and Sox2 ex-
pression was equally high in both cell populations, high-
lighting the undifferentiated state of sorted cells (Fig. 1F;
data not shown).Bmi1 transcript was consistently enriched
in GFP/Nanog-low ES cells, with relatively lower levels be-
ing detected in theNanog-high state (Fig. 1F). These results
indicate thatNanog dynamically regulates Bmi1 expression
in pluripotent cells and further suggest that Bmi1 might be
an early hallmark of differentiation.
Bmi1 is an early marker of extraembryonic endoderm
cell commitment
Remarkably, however, Bmi1 was not up-regulated in all
Nanog/ RCNbH(t) ES cells (n = 61/265) (data not shown),
but instead was selectively detected in a subset of cells that
coimmunostained for Gata6 (n = 58/61, P < 0.01, Wilcoxon
test) (Fig. 1G). This confined expression pattern was con-
firmed in tamoxifen-inducibleNanog/RCNbHBES cells,
where Bmi1 and Gata6 were promptly and simultaneously
induced upon Nanog depletion, followed by Gata4 and
Dab2—two late markers of the PrE lineage (Supplemen-
tal Fig. S2A; Yang et al. 2002; Capo-Chichi et al. 2005).
Colocalization of Bmi1, Gata6, and Gata4 protein in
Lavial et al.
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Nanog-depleted cells was verified by immunostaining
(Supplemental Fig. S2B), further pointing to a close as-
sociation between Bmi1 up-regulation and the acquisi-
tion of an extraembryonic cell identity. Consistently, we
found that Bmi1 was highly expressed in XEN cells as
well as in TS cells—two stem cell populations derived
from the PrE and TE lineages that lack Nanog, in contrast
to ES cells (Supplemental Fig. S3). Taken together, these
data demonstrate that Bmi1 is rapidly up-regulated in
PrE-like cells upon Nanog depletion and suggest a role for
Bmi1 in extraembryonic lineages.
Bmi1 is dynamically expressed alongside Nanog
and Gata6 in vivo
To explore this function, we investigated Bmi1 expres-
sion profile alongside Nanog and Gata6 in the early devel-
oping embryo. Bmi1 is a maternally inherited factor that
is highly expressed in cleavage stage embryos (Puschendorf
et al. 2008). Consistently, Bmi1 proteinwas homogeneously
detected in all blastomeres of four-cell stage embryos (Fig.
2A). From eight-cell up to the early morula stage (20 cells,
E3.0), Bmi1 overlapped in most cells with the nascent
Figure 1. Bmi1 is repressed by Nanog in ES cells and constitutes an early hallmark of extraembryonic differentiation. (A) Relative
transcript levels for Nanog, Oct3/4, Bmi1, and Gata6 as assessed by qRT–PCR in control RCN(t), Nanog/ RCNbH(t), and Nanog-
overexpressing EF4 ES cells maintained in self-renewing conditions. Data were normalized to S17 and L19 and expressed relative to
RCN(t) cells. Error bars represent the SD of three biological replicates. P-values were calculated using the Student’s t-test. (B)
Schematic representation of the Bmi1 locus (University of California at Santa Cruz Genome Browser NCBI37/mm9) showing
Nanog putative binding sites (BS; top panel) and abundance of Nanog at the Bmi1 BS1 and Gata6 promoter in RCN(t), RCNbH(t),
and EF4 ES cells (bottom panel). The arrow indicates the position of the Bmi1 transcription start site. The red line highlights a 1.9-
kb fragment from the Bmi1 regulatory region cloned into a pGL3 promoter vector for luciferase reporter assays as shown in C.
Nanog enrichment levels were assessed by ChIP and qPCR and expressed relative to input. Unspecific immunoprecipitation was
monitored by control IgG antibodies; background levels are denoted by dotted lines. Error bars represent the SD of three biological
replicates. P-values were calculated using the Student’s t-test. (C) Luciferase assay for Bmi1 regulatory region. HEK293T cells were
transfected with the Bmi1 regulatory region containing Bmi1 BS1 (Bmi1 Reg; AATCCATTATG) or its mutated version (Bmi1 Reg
MUT; AATCAGGCCTG) reporter constructs with or without Nanog. Luciferase activity was normalized to the control pGL3
promoter and Renilla. Error bars represent the SD of three biological replicates. P-values were calculated using the Student’s t-test.
(D) Example of Bmi1 and GFP/Nanog coimmunostaining in GFP/Nanog knock-in TNG ES cell colonies grown in self-renewing
conditions. Bars, 10 mm. (E) GFP intensity profile of TNG ES cells as assessed by FACS analysis. Gates used for sorting are indicated.
(F) Expression levels of GFP/Nanog, Oct3/4, Bmi1, and Gata6 as assessed in sorted GFPLow and GFPHigh TNG ES cells by qRT–PCR.
Error bars represent the SD of three biological replicates. P-values were calculated using the Student’s t-test. (G) Immunofluorescence analysis
showing the colocalization of Bmi1 and Gata6 in a subset of Nanog/ RCNbH(t) ES cells. Bars, 10 mm.
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Nanog and Gata6 protein (Fig. 2B; data not shown). This
pattern was dynamically altered around cavitation (E3.25),
when cell heterogeneity arose among blastomeres. In par-
ticular, we observed the emergence of a subpopulation of
cells (14.6%) that coexpress Bmi1 and Gata6 but not
Nanog (29- to 43-cell embryos; P < 0.0001, Wilcoxon
test) (Fig. 2B,C). Bmi1 protein staining became notice-
ably weaker in the developing blastocyst (E3.5–E4.5)
(data not shown) despite Bmi1 transcript being detected
throughout (see below), possibly reflecting a change in
Bmi1 post-translational modifications (Voncken et al.
2005). These data reveal a dynamic protein expression
pattern for Bmi1 and confirm its close association with
Gata6 in vivo.
Bmi1 preferentially cosegregates with Gata6 in PrE
progenitors in the developing blastocyst
Single-cell PCR analysis was exploited to dissect RNA
segregation events and further examine the relationship
between Bmi1 and Gata6 expression during epiblast/PrE
lineage specification. ICMs were isolated from blastocysts
by immunosurgery and dissociated into single blastomeres.
Embryos analyzed in these experiments were staged based
on the average cell number scored among littermates.
Bmi1 expression was then examined by qRT–PCR in each
individual blastomere, alongside Gapdh, Gata6, Gata4,
Nanog, and Ring1B (Fig. 3). In the early blastocyst (49- to
50-cell stage; E3.25), Gata6 and Nanog were expressed in
most, if not all, ICM cells, with little variability between
blastomeres (Fig. 3A, top panel). Mutually exclusive expres-
sion ofGata6 andNanog emerged at the 75- to 91-cell stage
(E3.5) (Fig. 3A, middle panel) and became more prominent
at the 163- to 227-cell stage (E4.5) (Fig. 3A, bottom panel)
(P < 0.05 at E3.5 and P < 0.01 at E4.5; Spearman test)
(Fig. 3B), as previously reported (Kurimoto et al. 2006;
Guo et al. 2010). At these developmental stages, Gata6
expression was correlated with Gata4 (P < 0.05 at E3.25
and P < 0.01 at E3.5 and E4.5, Spearman test), denoting PrE
lineage emergence and establishment within the ICM.
Bmi1 expression was similarly detected in almost all ICM
cells of the early blastocyst (E3.25), and its expression
was gradually restricted to Gata6-positive/Nanog-negative,
presumptive PrE cells (Fig. 3A). Remarkably, at E3.5
and E4.5, Bmi1 expression exhibited a significant cor-
relation with Gata6 (P < 0.01, Spearman test) (Fig. 3B).
In contrast, the expression of another PRC1 compo-
nent, Ring1B, did not correlate with Gata6 in the late
blastocyst (E4.5). These results establish that Bmi1
preferentially cosegregates with Gata6 at the tran-
script level in nascent PrE progenitors during blastocyst
development.
Bmi1 is physically associated with Gata6
in extraembryonic XEN cells
The observed association between Bmi1 and Gata6
prompted us to investigate a possible transcriptional
cross-regulation between the two factors. Ectopically ex-
pressing Bmi1 in ES cells did not, however, impact onGata6
expression. Conversely, Gata6 overexpression, carried out
as previously described (Fujikura et al. 2002; Shimosato
et al. 2007), only led to a slight increase in Bmi1mRNA
levels (data not shown), suggesting that no direct tran-
scriptional cross-regulation operates between Bmi1 and
Gata6. To test whether Bmi1 and Gata6 could be part of
a same protein complex, Cos-7 cells were cotransfected
with Gata6 and Bmi1, and cell lysates were subjected
Figure 2. Bmi1 protein expression profile in the early mouse embryo. (A) Bmi1 staining in a four-cell stage embryo as assessed by
immunofluorescence. (B) Examples of Bmi1 staining alongside Nanog and Gata6 in eight-cell, 29-cell, and 40-cell stage embryos. The
white arrow highlights an example of blastomeres coexpressing Bmi1 and Gata6 but not Nanog. (C) Counting of blastomeres expressing
Bmi1, Gata6, and/or Nanog in 29-cell up to 43-cell stage embryos (n = 26 embryos, 493 cells). P-values were calculated using the
Wilcoxon test.
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to anti-Gata6 immunoprecipitation. Bmi1 was strongly
coimmunoprecipitated with Gata6, as revealed by anti-
Bmi1 immunoblotting, thus demonstrating that Bmi1
andGata6 are indeed physically associated (Supplemental
Fig. S4A). Importantly, we confirmed that endogenous
Bmi1 and Gata6 protein can also be successfully coim-
munoprecipitated with anti-Bmi1 (Fig. 4A, top panel) or
anti-Gata6 (Fig. 4A,bottom panel) antibodies in XEN
cells and furthermore found this association to be DNA-
independent, as indicated by Benzonase treatment of the
protein extracts (data not shown). In contrast, the Bmi1
paralog Mel18 failed to interact with Gata6 in parallel
experiments, highlighting the specificity of Bmi1/Gata6 as-
sociation (Supplemental Fig. S4B). As expected, Bmi1 could
readily interact with other core PRC1 members expressed
in XEN cells, including Ring1B and Cbx8 (Supplemental
Fig. S4C, left panels). However, Gata6 was not detected in
the same complex (Supplemental Fig. S4C, right panels),
further suggesting that Bmi1/Gata6 interactionmight not
take place in a canonical PRC1 complex.
Bmi1 stabilizes Gata6 protein levels and enhances
its transcriptional activity
Critically, we next demonstrated that Bmi1/Gata6 asso-
ciation directly impacts on Gata6 stability and degrada-
tion in PrE derivatives. In this analysis, XEN cells were
stably transfected with two shRNAvectors targetingBmi1
(Supplemental Fig. S4D,E). Gata6 protein levels were
assessed in control (XENControl) and Bmi1 knockdown
(XENBmi1KD) XEN cells cultured for 0, 1, 2, and 4 h in the
presence of cycloheximide (CHX). Without protein syn-
Figure 3. Bmi1 RNA expression profile during epiblast/PrE lineage specification. (A) Gene expression analysis by qRT–PCR for
Gapdh, Gata6, Gata4, Bmi1, Nanog, and Ring1B in individual blastomeres derived from the ICMs of developing blastocysts; 49- to 50-
cell stage (E3.25) (top panel), 75- to 91-cell stage (E3.5) (middle panel), and 163- to 227-cell stage (E4.5) (bottom panel). Graphs represent
the estimated copy number of gene transcripts, with each colored bar corresponding to a single blastomere. Data were sorted based on
Gata6 transcript level. (B) Gene expression correlations between Gata6, Gata4, and Bmi1 in 49- to 50-cell stage (E3.25) (top panel), 75-
to 91-cell stage (E3.5) (middle panel), and 163- to 227-cell stage (E4.5) (bottom panel) embryos. Scatter plots represent the estimated
copy number of gene transcripts. Detection thresholds (Ct values >35) are denoted by red lines. P-values as indicated in the text were
calculated using the Spearman test.
Bmi1 favors PrE lineage emergence
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thesis, Gata6 protein levels gradually decreased in control
cells, with little or no effect on Gata6 transcription (Fig.
4B; data not shown). This trend was dramatically accel-
erated in the absence of Bmi1, suggesting that the Bmi1/
Gata6 interaction protects Gata6 from degradation. In
contrast, no such difference was detected in Gata4 pro-
tein decay (Fig. 4B), a factor that was not found to interact
with Bmi1 by coimmunoprecipitation in XEN cells (data
not shown). The addition of the proteasome inhibitor
MG132 alongside CHX confirmed that Gata factor deg-
radation was proteasome-dependent (Fig. 4C). Moreover,
blocking ubiquitination with the E1 ubiquitin ligase in-
hibitor PYR41 also abolished Gata protein degradation
(Fig. 4D), with Gata6 becoming detected in both the nu-
cleus and cytosol of treated cells (Supplemental Fig. S4F).
A role for Bmi1 in regulating this process was then di-
rectly validated by comparing the levels of Gata6 multi-
ubiquitination (Ub) in XENControl and XENBmi1KD cells
following proteasome inhibition. The absence of Bmi1
resulted in an increased accumulation of Gata6 ubiquiti-
nated forms (Fig. 4E), which strictly mirrors its decreased
protein stability (Fig. 4B). Gata4’s ubiquitination status
remained unchanged, as expected (Fig. 4E). Interestingly,
Bmi1-mediated Gata6 stabilization also enhanced the
transcriptional activity of Gata6, as assessed by luciferase
assays using a Gata6-dependent Hnf4 promoter reporter
(Morrisey et al. 1998) inXENcells in the presence or absence
of Bmi1 (Fig. 4F). Collectively, these results demonstrate
that Bmi1/Gata6 association regulates Gata6 protein sta-
bility and enhances its transcriptional activity through
the inhibition of Gata6 ubiquitination and proteasome-
mediated degradation.
Figure 4. Bmi1 interacts with Gata6 and regulates its stability and activity in XEN cells. (A) Coimmunoprecipitation of Gata6 and
Bmi1 proteins in XEN cells. Protein extracts were immunoprecipitated (IP) with control anti-IgG, anti-Bmi1 (top panel), or anti-Gata6
(bottom panel) antibodies and subjected to immunoblotting (IB) with anti-Gata6 and anti-Bmi1 antibodies, respectively. Three
independent experiments were performed with similar results. (B) Gata6 and Gata4 stability assay in control (XENControl) and Bmi1
knockdown (XENBmi1KD) XEN cells. Bmi1, Gata6, and Gata4 protein levels were assessed by immunoblotting in XENControl and
XENBmi1KD cells cultured with CHX for the indicated times. The amount of Gata6 and Gata4 protein was quantified using ImageJ
software and normalized to Actin as shown in graphs. Error bars represent the SD of four biological replicates. Similar results were
obtained using two independent shRNA vectors targeting Bmi1 in XEN cells (data not shown). (C,D) Same experiment as in B in the
presence of the proteasome inhibitor MG132 (1 mM) and E1 ubiquitin ligase inhibitor PYR41 (1 mM), respectively. (E) Gata6 and Gata4
ubiquitination levels in XENControl and XENBmi1KD cells. XENControl and XENBmi1KD cells were cultured for 7 h in the presence of
MG132. Protein extracts were subjected to immunoprecipitation with anti-Gata6 (left panel) or anti-Gata4 (right panel) antibodies, and
the levels of multiubiquitination (Ub) were revealed by immunoblotting with anti-ubiquitin antibodies. Anti-Gata6 and anti-Gata4
immunoblots confirm the uniform recovery of Gata6 or Gata4 protein by immunoprecipitation across cell samples. (F) Gata6 reporter
assay in XENControl and XENBmi1KD cells. Both cell populations were transiently transfected with Gata6-dependent Hnf4 reporter, and
luciferase activity was assessed 48 h post-transfection. Data were normalized to Renilla. Error bars represent the SD of three biological
replicates. The P-value was calculated using the Student’s t-test.
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The C-terminal domain of Gata6 mediates its
interaction with Bmi1 and ubiquitin-dependent
degradation
In an attempt to establish which domain of Gata6 was
critical for ubiquitin-dependent proteasome degradation,
we next generated truncated Gata6 mutants lacking the
C-terminal domain alone (DCT) or including its zinc
finger region (DCTZF), where putative lysine ubiquitina-
tion sites are preferentially mapped (highlighted by aster-
isks in Fig. 5A). Flag-tagged wild-type, DCT, or DCTZF
Gata6 constructs were transfected into Cos-7 cells, and
Gata6 protein decay and ubiquitination status were
assessed as previously performed (Fig. 4). Both deletions
resulted in an increased Gata6 protein stability (Fig. 5B)
and a reduced sensitivity to ubiquitination (Fig. 5C), iden-
tifying the C-terminal domain as being critical for Gata6
degradation via ubiquitination. Moreover, this domain was
found to be equally important for Gata6 interaction with
Bmi1, as demonstrated by coimmunoprecipitation assays
(Fig. 5D). Conversely, using a similar mutagenesis approach
for Bmi1, we validated that Bmi1/Gata6 interaction is me-
diated via the Bmi1Ring finger domain (Fig. 5E,F; Hosokawa
et al. 2006) and furthermore demonstrated that an intact
Bmi1 is required for enhancing Gata6 transcriptional ac-
tivity (Fig. 5G). Taken together, these results reiterate the
functional importance of Bmi1/Gata6 interaction and
further suggest how Bmi1 binding can confer protection
against Gata6 ubiquitination and degradation, most likely
bymasking lysine residues in theGata6C-terminal domain
from ubiquitin-conjugating enzymes.
Bmi1 promotes the emergence of PrE-like
cells upon EB formation
The experiments described thus far show that Bmi1 coseg-
regates with Gata6 in PrE derivatives, where it interacts
with and stabilizes Gata6 protein levels. This suggests an
early developmental function for Bmi1 in regulating extra-
embryonic endoderm lineage formation that we investi-
gated in ES-derived EBs. In this system, ES cells are
induced to form aggregates in hanging drops, and differ-
entiation is allowed to proceed over 5 d. During this time
window, PrE- and epiblast-like cells first emerge in a salt-
and-pepper manner (Rula et al. 2007). They then segregate
with the formation of an organized, outer PrE-like layer
that costains for Bmi1, Gata6, and Gata4, as visualized
by immunofluorescence on day 5 EBs (Fig. 6A). As pre-
viously reported, Nanog-overexpressing EBs were not
capable of forming a proper outer layer (Chambers et al.
2003; Niakan et al. 2010), and this phenotype was
associated with a loss of Bmi1 induction alongside Gata6
and Gata4 (data not shown).
To directly assess the effect of Bmi1 depletion on this
process, Bmi1 knockdown ES cells were established by
stable transfection with different Bmi1 shRNA vectors.
These cells showed no increased incidence of differenti-
ation when grown in self-renewing conditions (data not
shown). Importantly, Bmi1 knockdown was efficiently
maintained upon EB formation, as assessed at the mRNA
and protein levels (Fig. 6B; data not shown). Here, we
observed a pronounced defect on PrE-like cell differenti-
ation in the absence of Bmi1. While Oct3/4 and Nanog
were down-regulated in both control and Bmi1 knock-
down EBs, the induction of the PrE markers Gata6 and
Sox17 was impaired (Fig. 6B), with no proper outer layer
organization (Fig. 6C). This phenotype most closely re-
sembles that of Gata6/ EBs but differs from that of
Sox17/ EBs, in accord with Bmi1 action on Gata6 sta-
bility (Fig. 4; Koutsourakis et al. 1999; Fujikura et al. 2002;
Niakan et al. 2010; Artus et al. 2011). Moreover, and as
shown in Figure 6C, only very few PrE-like, Bmi1-depleted
cells emerged, and these cells expressed Gata4 protein
alongside Gata6, further highlighting that the emergence
of PrE-like progenitors, rather than their maturation,
might be directly affected by Bmi1 depletion.
Bmi1 biases cell fate toward a PrE identity
in a cell-autonomous manner
To assess whether the observed defect was cell-autono-
mous, we repeated these experiments and mixed control
(ESControl) cells with Bmi1 knockdown (ESBmi1KD) ES cells
to form chimeric EBs. Cells were first labeled by stable
Gfp transfection followed by FACS sorting, and the GFP-
labeled ESControl or ESBmi1KD cells aggregated with un-
labeled ESControl cells upon EB formation (Fig. 6D). The
fate of labeled cells was assessed based on their position
within the EB structure (inner/outer), and the emergence
of PrE-like cells was monitored by looking at Gata6
expression (Fig. 6E; Supplemental Fig. S5). Remarkably,
GFP-ESBmi1KD cells were preferentially located within the
inner part of EBs (P < 0.05, Student’s t-test) (Supplemental
Fig. S5A), in contrast to GFP-ESControl cells, which
appeared to be evenly distributed. This observation was
consistent with a lower frequency of Gata6-positive,
GFP-ESBmi1KD cells detected in day 5 EBs as compared
with controls (P < 0.005, Student’s t-test) (Supplemental
Fig. S5B). Taken together, these results demonstrate a di-
rect role for Bmi1 in cell allocation between a PrE- and an
epiblast-like fate upon EB formation.
Discussion
In this study, we identify a novel role for the Polycomb
group member Bmi1 in regulating cell fate choice between
extraembryonic endoderm and pluripotent lineages (Fig.
7). We show that Bmi1 is readily detected in vivo in all
blastomeres of cleavage stage embryos and overlaps with
Nanog and Gata6 from the eight-cell stage onward. This
pattern dynamically changes upon blastocyst formation,
when Bmi1 becomes mosaic among ICM cells, preferen-
tially cosegregating with Gata6 in nascent PrE progenitors.
Critically, we demonstrate that Bmi1 controls Gata6 pro-
tein stability and its resultant activity by conferring pro-
tection against ubiquitination and proteasome-dependent
degradation, as confirmed by Bmi1 knockdown in XEN
cells. This effect is thought to be mediated through Bmi1/
Gata6 interaction via the Bmi1 Ring domain, which could,
in turn, alter Gata6 protein conformation and/or mask
lysine residues in the Gata6 C-terminal domain from
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Figure 5. The C-terminal domain of Gata6 is critical to trigger its ubiquitin-dependent degradation and interacts with the Bmi1
Ring domain. (A) Scheme depicting Flag-tagged Gata6 wild-type and truncated forms. Wild-type Gata6 (Wt) mouse cDNA was
flagged, and mutants lacking either the C-terminal domain (DCT) alone or including its zinc finger region (DCTZF) were generated
by PCR-based mutagenesis. Asterisks highlight the location of putative ubiquitination lysine sites in Gata6 protein. (B)
Comparative protein stability assay using wild-type (Wt) and mutant Gata6 forms. Cos-7 cells were transiently transfected with
wild-type, DCT, or DCTZF Gata6. Flagged Gata6 protein levels were assessed by immunoblotting following CHX treatment for the
indicated times. The amount of Gata6 protein was quantified using ImageJ software and normalized to Actin as shown in graphs.
Error bars represent the SD of three biological replicates. (C) Ubiquitination status of Gata6 mutant forms. Cos-7 cells were
transiently transfected with Flagged wild-type, DCT, or DCTZF Gata6 and cultured for 7 h in the presence of MG132. (Top panel)
Protein extracts were subjected to immunoprecipitation with anti-Flag antibodies, and the levels of Gata6 multiubiquitination
(Ub) were revealed by immunoblotting with anti-ubiquitin antibodies. Anti-Flag immunoblots confirmed the efficient recovery of
Gata6 protein following immunoprecipitation across cell samples. (D) Coimmunoprecipitation of Bmi1 and Gata6 mutant forms.
(Bottom panel) Cos-7 cells were transiently cotransfected with Flag-tagged wild-type, DCT, or DCTZF Gata6 and Myc-tagged Bmi1,
and protein extracts were immunoprecipitated (IP) with anti-Flag antibodies and subsequently subjected to immunoblotting (IB)
with anti-Flag (recovery control) or anti-Myc antibodies to detect Bmi1 protein. (E) Scheme depicting Myc-tagged wild-type and
truncated Bmi1 forms. Bmi1 mouse cDNA was Myc-tagged (wild-type [Wt]), and a mutant lacking the Ring domain (DRing) was
generated. (F) Coimmunoprecipitation of Gata6 and wild-type or DRing Bmi1. Cos-7 cells were transiently cotransfected with
Gata6 and Myc-tagged wild-type or DRing Bmi1, and protein extracts were subjected to immunoprecipitation (IP) with anti-Myc
antibodies (top panel) and immunoblotting (IB) with anti-Gata6 antibodies (bottom panel). Inputs and anti-Myc immunoblots
confirmed homogeneous levels of different transfected forms. Three independent experiments were performed with similar
results. (G) Gata6 reporter assay using wild-type and DRing Bmi1 forms. HEK293 cells were transiently cotransfected with Gata6-
dependent Hnf4 reporter and wild-type versus DRing Bmi1 constructs, and luciferase activity was assessed 48 h post-transfection.
Data were normalized to Renilla. Error bars represent the SD of three biological replicates. The P-value was calculated using the
Student’s t-test.
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ubitiquin-conjugating enzymes (Clurman et al. 1996). Im-
portantly, we establish that Bmi1 plays a cell-autonomous
role in promoting the induction of the PrE lineage, as
assessed in vitro in chimeric EBs. In the context of the early
embryo, Gata6 and Nanog expression is first stochastic
(Dietrich and Hiiragi 2007), and cell fate is thought to
remain flexible (Yamanaka et al. 2010). We propose here
that Bmi1 action on Gata6 stability could directly alter
the balance between Gata6 and Nanog protein levels in
individual blastomeres and thus impact on cell fate
Figure 6. Bmi1 promotes PrE emergence in a cell-autonomous manner. (A) Coimmunostainings for Bmi1, Gata6, and Gata4 were
performed on agarose-embedded and microsectioned EBs cultured for 5 d. (B) Relative transcript levels for Bmi1, Oct3/4, Nanog, Gata6,
Gata4, and Sox17 as assessed by qRT–PCR in control (ESControl) and Bmi1 knockdown (ESBmi1KD) ES cells upon EB formation for 5 d. Data
were normalized to S17 and L19 and expressed relative to undifferentiated ESControl cells. Error bars represent the SD of two biological
replicates. (C) Coimmunostainings for Gata6 and Gata4 performed on EBs cultured for 5 d in the presence (ESControl; top panel) or absence
(ESBmi1KD; bottom panel) of Bmi1. Bars, 20 mM. (D) Schematic of chimeric EB formation. GFP-labeled ESControl or ESBmi1KD cells were mixed
with unlabeled ESControl cells (ratio 1/1–1/3) and allowed to differentiate for 5 d upon EB formation. (E) Coimmunostainings for GFP and
Gata6 performed on chimeric EBs formed as described in D. The outer layer of the EB structure is denoted by dotted lines. Bars, 20 mM.
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decisions by introducing a bias toward a PrE identity.
Interestingly, Gata4 does not interact with Bmi1, and this
together with the late onset of Gata4 protein expression
in vivo further suggests that Gata4 and Sox17 could, in
turn, reinforce Gata6 function in a Bmi1-independent
manner.
Interestingly, we provide novel evidence that Nanog
represses Bmi1 in ES cells, as forGata6 (Fig. 7; Singh et al.
2007), further supporting the view that Nanog actively
suppresses the PrE identity in pluripotent cells while
being required for proper PrE differentiation in a non-cell-
autonomous manner (Silva et al. 2009; Messerschmidt
and Kemler 2010; Frankenberg et al. 2011). We demon-
strate that Bmi1 expression mirrors Nanog fluctuations
within ES cell cultures and constitutes an early hallmark
of extraembryonic differentiation upon Nanog depletion.
Interestingly, while Bmi1 protein expression is mutually
exclusive with Nanog, the Bmi1 transcript remained
detected, although at variable levels, in Nanog-high and
Nanog-low ES cell populations (Fig. 1), suggesting that
Bmi1 itself may be post-transcriptionally regulated in this
context. Several microRNAs were previously shown to
target the Bmi1 39 untranslated region (UTR) in various
cancer cell lines (Shimono et al. 2009). Here we identified
miR-200c as being uniquely expressed in ES cells, as
opposed to XEN and TS cells (Supplemental Fig. S6A), and
positively regulated by Nanog (Supplemental Fig. S6A,B).
Moreover, inhibiting miR-200c was found sufficient to
release Bmi1 protein expression in ES cells (Supplemental
Fig. S6C,D), adding another level of Bmi1 expression
control mediated by Nanog (Fig. 7). Conversely, we found
that ectopic expression of Bmi1 in ES cells reduces Nanog
mRNA levels without altering Oct4, Sall4, or Klf4, yet is
not capable of driving PrE differentiation alone (data not
shown). Similar cross-regulatory events between Bmi1 and
Nanog might also take place in vivo as Bmi1/Gata6 and
Nanog transcripts segregate upon epiblast/PrE lineage spec-
ification, a pattern that is stably established in the late
blastocyst by E4.5. By comparison, Bmi1 and Gata6 pro-
tein were seen to cosegregate in a subset of blastomeres in
the early blastocyst around E3.25, suggesting that the
Bmi1/Gata6 protein–protein interaction could be an early
event in PrE emergence, while Nanog-mediated tran-
scriptional repression of Bmi1, Gata6, and other factors
would ‘‘lock in’’ or reinforce the epiblast/pluripotent
identity both in vivo and in vitro. Additional mecha-
nisms, such as the timing of cell internalization and sig-
naling cascades, have also been shown to act in concert to
dictate or consolidate PrE lineage specification (Nichols
et al. 2009; Morris et al. 2010; Yamanaka et al. 2010).
Bmi1 is a pleiotropic factor with roles linked to cell cycle
regulation and cancer (Bruggeman et al. 2007; Grinstein
andMahotka 2009) as well as to the homeostasis of adult
stem cells (van der Lugt et al. 1994; Molofsky et al. 2003;
Park et al. 2003; Bruggeman et al. 2007). Our study unveils
a previously unrecognized developmental function for
Bmi1 (Puschendorf et al. 2008), acting as a key post-
transcriptional regulator of Gata6, a factor essential for
extraembryonic endoderm development both in vitro and
in vivo (Koutsourakis et al. 1999; Lim et al. 2008). Of
interest, Bmi1was also found to interact withGata3 in TE-
derived TS cells (Supplemental Fig. S7A; Home et al. 2009;
Ralston et al. 2010). Bmi1 depletion in TS cells notably led
to a loss of stem cell identity accompanied by a rapid and
drastic reduction in Gata3 protein levels (Supplemental
Fig. S7B–E). This indicates that Bmi1might regulate Gata3
protein expression in TS cells and suggests a broader role
for Bmi1 in the formation and/or maintenance of extra-
embryonic lineages during early mouse development.
Materials and methods
Cell culture
Mouse ES, TS, and XEN cell lines were grown as previously
described (Tanaka et al. 1998; Kunath et al. 2005; Alder et al.
2010). For Nanog depletion, the RCNbHB cell line was treated
with 1 mg/mL 49-OH-tamoxifen (Chambers et al. 2007). Trans-
fections were carried out using Lipofectamine 2000 (Invitrogen,
11668) following themanufacturer’s recommendations. For stable
clone derivation, cells were treated 24 h post-transfection with
puromycin (Sigma, p8833) at 1 mg/mL for 8–10 d. Clones were
then pooled or picked individually, depending on the experi-
mental design. EB formation was induced in hanging drops as
previously described (Lavial et al. 2007).
Antibodies
Anti-Bmi1 (Millipore ,F6), anti-Gata6 (R&D Systems, AF1700),
anti-Gata4 (Santa Cruz Biotechnology, sc-9053), anti-Gata3
Figure 7. Model of Bmi1 function in extraembryonic endoderm
lineage emergence. Nanog transcription factor protects the
pluripotent state by repressing Bmi1 and Gata6 PrE-associated
genes (depicted as black solid lines) and activating miR-200c,
a microRNA also shown to modulate Bmi1 protein expression in
ES cells (depicted as a black dotted line, indicating no evidence that
this regulation is direct). (BS) Location of the Nanog-binding site
upstream of the Bmi1 and miR-200c transcription start sites
(arrows). Bmi1 physically interacts with and stabilizes Gata6 pro-
tein levels by protecting it from ubiquitination and proteasomal
degradation (depicted as red triangles and dashed box). Formation of
this complex enhances Gata6 transcriptional activity on target
genes and promotes PrE emergence. Gata6 lies upstream of Gata4
and Sox17 in differentiation cascade (depicted as red dotted lines,
indicating no evidence that these regulations are direct). Bmi1
expression also leads to a reduction inNanog levels by an unknown
mechanism (depicted as a black dotted line).
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(Santa Cruz Biotechnology, sc-268), anti-Cdx2 (Biogenex,
MU392A-UC), anti-Nanog (Cosmobio, RCA B000 2P-F), anti-
ubiquitin (Biomol, FK2), anti-Ring1B (Active Motif, 39663), anti-
Cbx8 (Bethyl Laboratories, A300-882A), anti-Mel18 (Abcam,
ab5267), anti-GFP (Abcam, AB290), anti-Myc (Santa Cruz Bio-
technology, sc-40), anti-Flag (Sigma,M2), and anti-Actin (Abcam,
AB8227) were used. For immunoprecipitation experiments, anti-
Gata6 (Santa Cruz Biotechnology, sc-9055) was used. For immuno-
fluorescence, Alexa secondary antibodies were used (Invitrogen).
For immunoblotting and coimmunoprecipitation experiments,
mouse (Santa Cruz Biotechnology), rabbit (Santa Cruz Biotech-
nology), and goat (Dako) secondary antibodies were used.
RNA expression analysis
Total RNA was isolated using the Qiagen RNeasy minikit and
DNase I-treated. Samples were oligo(dT) reverse-transcribed using
Invitrogen SuperScript III or M-MLV following the manufacturer’s
recommendations and analyzed by qRT–PCR using Sigma Jump-
start SYBR Green. Primer sequences are available on request.
Vector construction
pLKO.1 vectors containing hairpins directed against Bmi1 cDNA
were purchased from Sigma: shRNA vector 1 (CCGGCCAGCAA
GTATTGTCCTATTTCTCGAGAAATAGGACAATACTTGCT
GGTTTTT) and shRNA vector 2 (CCGGCCTGAACATAAG
GTCAGATAACTCGAGTTATCTGACCTTATGTTCAGGTT
TTT). The Bmi1 2.4-kb promoter was PCR-amplified on mouse
ES cell genomic DNA using long expand Taq (Roche Biomed-
icals, 11681834001) and Bmi1prom-F (59-TCCCTGCCAGACT
GTTTCTT-39) and Bmi1prom-R (59-CGTAAATGACCACGGG
GATT-39) primers. Taq polymerase (Invitrogen 10342-020) was
used to add adenines and clone the fragment into pGEMTeasy
(Promega, TM042). The Bmi1 1.9-kb promoter fragment was then
subcloned into the pGL3 promoter (Promega, E1761) using MluI
and BglII restriction enzymes (New England Biolabs). Mutations
in the Nanog-binding site BS1 were inserted by using PfuTurbo
polymerase (Stratagene 600250), DpnI restriction enzyme (New
England Biolabs), and Bmi1mut-F (59-TAAAATGTCTGGTCGC
AGACTGCAATTGTCAGGCCTGATTAAGAGCGTACTTTAA
GACAAATCACTT-39) and Bmi1mut-R (59-AAGTGATTTGTCT
TAAAGTACGCTCTTAATCAGGCCTGACAATTGCAGTCTG
CGACCAGACATTTTA-39) primers. Gata6 cDNAwas subcloned
in the BglII site of pSG5-Flag (Stratagene) using primers G6-F (59-
ATAGATCTAGCCTTGACTGACGGCGGC-39) and G6-R (59-AT
AGATCTATCAGGCCAGGGCCAGAGC-39). Gata6 truncated
forms were generated with primers DCTZF-F (59-CCTGTCG
GAGAGCCGCTGATAGATCTGGTACC-39), DCTZF-R (59-GGT
ACCAGATCTATCAGCGGCTCTCCGACAGG-39),DCT-F (59-GG
AATTCAAACCAGGAAACGAAAATGATAGATCTGGTACC
ACTA-39), and DCT-R (59-TAGTGGTACCAGATCTATCATTT
TCGTTTCCTGGTTTGAATTCC-39). Recombinant lentiviruses
were generated using a three-plasmid system in 293T cells as pre-
viously described (Kutner et al. 2009). Virus-containing culture su-
pernatants were collected 24 and 48 h after transfection, pooled,
concentrated, and used for infection. Control and Bmi1KD-infected
TS cells were collected 4 d post-infection as previously described
(Alder et al. 2010). TheGata6-dependentHnf4 promoter was cloned
into the pGL3 promoter as previously described (Morrisey et al.
1998). miR-200c inhibitor was purchased from Exiqon and trans-
fected following the manufacturer’s recommendations.
Luciferase reporter assay
Luciferase assays were carried out using 2.53 105 HEK293Tcells
in 96-well plates. Transfections with pGL3 promoter vectors and
control peGFPC1 (Clontech) or pRenilla-Tk (Promega) were
performed using Lipofectamine 2000 (Invitrogen, 11668-019).
Luciferase activity was assessed 48 h post-transfection using
a Steadylite kit (PerkinElmer, 6016756) following the manufac-
turer’s recommendations. Transfection efficiency was corrected
using GFP or Renilla levels.
Immunoblotting analysis
Cells lysis was carried out using RIPA buffer (50mMTris at pH 8,
1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0,1% sodium
deoxycholate, 140 mM NaCl) supplemented with a protease
inhibitor tablet (Roche Diagnostics, 11836153001). Protein frac-
tionation was performed using NE-PER kit (Thermo Fisher
Scientific, 78833). Protein concentrations of whole-cell extracts
were measured using a Bradford assay (Thermo Fisher Scientific,
23225). Thirty-microgram samples were loaded onto 10% acryl-
amide gels and blotted onto methanol-activated polyvinylidene
fluoride membranes (Millipore, IPFL00010) using a semidry or
wet transfer system. Membranes were treated with enhanced
chemiluminescent substrate (Thermo Fisher Scientific, 32106).
ChIP and coimmunoprecipitation
ChIP was carried out as previously described (Alder et al. 2010).
For coimmunoprecipitation experiments, 800 mg of cell protein
extracts was precleared with protein A Sepharose beads (Sigma,
P3391) for 2 h at 4°C and then incubated overnight at 4°C with
the indicated antibodies. Protein A beads were then added for 5 h,
washed with RIPA and TSE buffer (2 mM EDTA, 20 mM Tris at
pH 8, 150 mMNaCl) four times, and loaded on either 7% or 14%
acrylamide gels. Protein extracts were treated for 2 h at 4°Cwith
50 U of Benzonase (Merck, 71205) where indicated.
Protein stability assay
Cells were split, and 3 3 106 cells were plated back into 10-cm
plates. On the following day, cells were treated with 100 mM
CHX (Sigma), CHX plus 1 mM MG132 (Calbiochem, 474790), or
CHX plus 1 mM PYR41 (Calbiochem, 662105) for the indicated
times. Protein amounts were quantified using ImageJ software
and normalized to Actin levels.
Ubiquitination assay
Cells were treated for 7 h with 1–5 mM MG132, lysed in the
presence of deubiquitination inhibitor NEM (Sigma, E3876), son-
icated, and subjected to overnight immunoprecipitation with
control anti-IgG, anti-Gata6, anti-Gata4, or anti-Flag antibodies.
Protein G beads (GE Healthcare, 17-0618-01) were added for 4 h
at 4°C, and the levels of ubiquitination were subsequently re-
vealed by immunoblotting with anti-ubiquitin antibody.
Immunofluorescence analysis
Cells were seeded on gelatinized glass coverslips and fixed in PBS
with 4% paraformaldehyde. Samples were permeabilized and
blocked at room temperature before incubation with the indi-
cated antibodies. Coverslips were mounted on VectaShield with
DAPI (Vector Laboratories, H-1200) and examined using a Leica
SP5 confocal microscope (403 or 633 lens). Embryo immuno-
stainings were performed as previously described (Chazaud et al.
2006). EBs were fixed overnight in formalin at 4°C and embedded
in agarose and wax. Five micromolar sections were used for
stainings and observations on a Leica SP5 confocal microscope.
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Embryo collection and staging for single-cell PCR analysis
BL/6xC3H F1 mice were bred naturally, and the embryos were
recovered at E3.25, E3.5, or E4.5 by flushing either the oviduct or
uterus. ICMs were isolated from blastocysts by immunosurgery
and further dissociated into single blastomeres by pipetting in
a solution of 1 mM EDTA dissolved in HBS after treatment with
1% trypsin (Sigma, T-4549) and 1 mM EDTA in HBS. Staging of
embryos subjected to single-cell PCR analysis was defined as
follows. Upon recovery, average-size embryos were selected for
subsequent analysis, and the remaining littermates were fixed in
PBS with 4% paraformaldehyde (Electron Microscopy Sciences,
19208) and stained in PBS with 10 mM DAPI (Molecular Probes,
D3571) and 5 U/mLAlexa Fluor 633 or Alexa Fluor 564 phalloidin
(Molecular Probes, A22284 or A22283, respectively). Images were
acquired on a Zeiss LSM 510 META or 710 microscope and an-
alyzed using IMARIS software (Bitplane). The total cell number of
each embryo was counted, and an average cell number of litter-
mates (excluding those with maximum and minimum cell num-
bers) was used to define the developmental stage of each embryo
processed for single-cell PCR analysis. Experiments were per-
formed in accordance with European Union guidelines for the
care and use of laboratory animals.
Single-cell cDNA amplification
Single-cell cDNA amplification from each blastomere was per-
formed as previously reported (Kurimoto et al. 2006). Briefly,
single blastomeres were lysed in individual tubes without
purification, and first strand cDNAs were synthesized using a
modified poly(dT)-tailed primer. The unincorporated primer
was specifically digested by exonuclease, and the second strands
were generated with a second poly(dT)-tailed primer after
poly(dA) tailing of the first strand cDNAs. The cDNAs were
amplified by PCR first with poly(dT)-tailed primers and sub-
sequently with primers bearing the T7 promoter sequence. The
resultant cDNA products were used for further real-time PCR
analysis. Primer sequences are available on request. Note that
‘‘spike’’ RNAs that consist of poly(A)-tailed RNAs artificially
designed from Bacillus subtilis genes were added to each sample
as amplification control to estimate the copy number of gene
transcripts analyzed. Amixture of four distinct ‘‘spike’’ RNAs—Lys,
Thr, Phe, and Dap (American Type Culture Collection 87482,
87483, 87484, and 87486)—were prepared so that each tube
contained 1000, 100, 20, and five copies of each spike RNA,
respectively.
Statistics analysis
Statistical analyses were performed using GraphPad Prism 5. For
single-cell PCR analysis, the Spearman’s rank correlation co-
efficient test was performed using R software to evaluate gene
expression correlations with Gata6.
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